市場調查報告書
商品編碼
1423621
到 2030 年數位心理治療市場預測:按類型、解決方案、經營模式、應用、最終用戶和地區進行的全球分析Digital Psychotherapeutics Market Forecasts to 2030 - Global Analysis By Type, Solution, Business Model, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球數位心理治療市場規模將達到10.6億美元,預計在預測期內將以27.6%的複合年成長率成長,到2030年達到102.5億美元。
數位心理治療是指利用行動應用程式和線上平台等數位技術為心理健康問題提供治療性介入。這些解決方案通常結合認知行為療法 (CBT) 和正念等實證治療技術,並且可以為尋求心理健康護理的個人提供遠端支援。
根據澳洲統計局預測,2022年,21.5%的人會出現為期12個月的精神障礙,其中以焦慮症最為常見(16-85歲族群為17.2%)。此外,世界上八分之一的人患有精神障礙。
精神疾病呈上升趨勢
社會壓力的增加、經濟的不確定性以及數位時代的影響導致了心理健康障礙的激增。此外,高壓職場環境和經常接觸的現代生活方式可能會加劇心理健康挑戰,並導致心理健康障礙的盛行率顯著增加。數位心理治療利用科技提供可擴展和個人化的介入措施,使心理健康支援更加廣泛。個人和醫療保健提供者擴大轉向數位解決方案,以應對與精神健康障礙相關的日益嚴峻的挑戰,而需求的激增正在推動市場擴張。
資料隱私和安全問題
心理健康資料的敏感性使其成為網路威脅的有吸引力的目標,並可能導致未授權存取和濫用。由於擔心違反保密性,患者可能會猶豫是否採用數位心理治療解決方案。建立強大的加密和身份驗證機制對於向用戶灌輸信任至關重要,但資料外洩的威脅仍然是一項重大挑戰,阻礙了數位心理治療的普及。
方便用戶使用的平台和應用程式的興起
使用者友善的平台和應用程式利用以使用者為中心的設計和先進技術來提高心理健康干預措施的可及性和參與度。這些新興平台專注於便利性和個人化體驗,正在迎合更廣泛的受眾,並推動數位心理治療的廣泛採用。隨著對無障礙心理健康解決方案的需求持續成長,市場有望透過這些方便用戶使用的應用程式擴大。
與傳統治療方法的競爭
儘管數位解決方案具有便利性和可訪問性的優點,但一些個人和醫療保健提供者仍然更喜歡或依賴傳統的治療方法。對數位心理治療的有效性和可靠性的懷疑可能會阻礙其被接受。對眾所周知的方法的依賴和傳統治療方法的個人化性質有助於形成競爭形勢。因此,傳統治療方法的既定聲譽和長期接受度將是市場吸引力的關鍵挑戰。
COVID-19 的影響
COVID-19 大流行顯著加速了數位心理治療的採用,在全球心理健康挑戰日益惡化的情況下,需求激增。人們對心理健康意識的不斷提高,加上關門和社交距離,促使人們轉向遠端和數位心理健康解決方案。遠端醫療平台、心理健康應用程式和虛擬支援工具推動了數位心理治療市場的發展,並獲得了很高的接受度。
穿戴式裝置市場預計將在預測期內成為最大的市場
預計穿戴式裝置產業將出現利潤豐厚的成長。透過將科技融入心理健康干預措施,穿戴式裝置在數位心理治療中發揮關鍵作用。這些設備通常佩戴在身上,收集即時生理資料並實現個人化、資料驅動的治療。透過監測生命徵象、睡眠模式和活動量並向治療師提供客觀的見解來提高治療效果。這種連續的資料流有助於更有針對性的干涉,並能夠及時調整治療計劃。
焦慮症產業預計在預測期內複合年成長率最高
焦慮症產業預計在預測期內將出現最高的複合年成長率。數位心理治療透過提供可訪問的、個人化的和可擴展的干涉措施,為焦慮症提供了一個有前途的解決方案。這些平台通常結合實證治療技術、認知行為治療模組和正念練習來解決焦慮症狀。方便靈活的心理保健方法正在推動這一領域的需求。
由於人們對心理健康問題的認知不斷提高、智慧型手機普及不斷提高以及技術進步,亞太地區預計將在預測期內佔據最大的市場佔有率。 COVID-19 大流行對心理健康的影響提高了該地區對遠端醫療的接受度。中國以其強大的技術基礎設施而聞名,遠端醫療、行動醫療應用和穿戴式裝置在中國取得了巨大進步。因此,遠端醫療和數位醫療技術的強勁進步可能會繼續推動該地區的成長。
由於有利的贖回情況,預計北美在預測期內將出現最高的複合年成長率。隨著美國的數位心理治療產業預計將持續發展。焦慮、憂鬱症和創傷後壓力症候群(PTSD)是美國常見的精神疾病。北美是塑造數位心理治療未來、推動創新和可近性的關鍵參與者。該地區完善的醫療基礎設施,加上數位干預措施的接受度不斷提高,正在推動市場擴張。
According to Stratistics MRC, the Global Digital Psychotherapeutics Market is accounted for $1.06 billion in 2023 and is expected to reach $10.25 billion by 2030 growing at a CAGR of 27.6% during the forecast period. Digital psychotherapeutics refers to the use of digital technologies, such as mobile apps and online platforms, to deliver therapeutic interventions for mental health issues. These solutions often incorporate evidence-based therapeutic techniques, such cognitive-behavioural therapy (CBT) or mindfulness, and can provide remote and accessible support to individuals seeking mental health care.
According to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16-85 years). In addition, 1 out of every 8 individuals in this world suffers from a psychological disorder.
Increasing mental health disorders
The heightened societal stressors, economic uncertainties and the impact of the digital age surge in mental health disorders. Also, modern lifestyles, with high-pressure work environments and constant connectivity, may exacerbate mental health challenges, leading to a notable increase in the prevalence of mental health disorders. Digital psychotherapeutics leverage technology to offer scalable, personalized interventions, making mental health support more widely available. This surge in demand is driving the expansion of the market, as individuals and healthcare providers increasingly turn to digital solutions to address the escalating challenges associated with mental health disorders.
Data privacy & security concerns
The sensitive nature of mental health data makes it a prime target for cyber threats, potentially leading to unauthorized access and misuse. Patients may hesitate to adopt digital psychotherapeutic solutions due to fears of breaches in confidentiality. Building robust encryption and authentication mechanisms is crucial to instill trust among users, but the persistent threat of data breaches remains a key challenge, impeding the widespread adoption of digital psychotherapeutics.
Rising user-friendly platforms & apps
The user-friendly platforms and apps leverage user-centric design and advanced technologies to enhance accessibility and engagement in mental health interventions. With a focus on convenience and personalized experiences, these rising platforms cater to a broader audience, fostering increased adoption of digital psychotherapeutics. As the demand for accessible mental health solutions continues to rise, the market is poised for expansion through these user-friendly applications.
Competition with traditional therapies
While the convenience and accessibility of digital solutions offer advantages, some individuals and healthcare providers may still prefer or rely on traditional therapeutic approaches. Skepticism around the efficacy and reliability of digital psychotherapeutics may impede their acceptance. Trust in well-known methods and the personalized nature of traditional therapy contributes to the competitive landscape. Therefore, the established reputation and long-standing acceptance of traditional therapeutic methods pose a significant challenge for the market to gain traction.
Covid-19 Impact
The covid-19 pandemic has significantly accelerated the adoption of Digital Psychotherapeutics, witnessing a surge in demand as mental health challenges escalated globally. The increased awareness of mental well-being, coupled with lockdowns and social distancing measures, prompted a shift towards remote and digital mental health solutions. Teletherapy platforms, mental health apps, and virtual support tools experienced heightened acceptance, driving the digital psychotherapeutics market.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in digital psychotherapeutics by integrating technology into mental health interventions. These devices, often worn on the body, collect real-time physiological data, enabling personalized and data-driven therapy. They enhance therapy effectiveness by monitoring vital signs, sleep patterns, and activity levels, providing therapists with objective insights. This continuous data stream fosters more targeted interventions and allows for timely adjustments to treatment plans.
The anxiety disorders segment is expected to have the highest CAGR during the forecast period
The anxiety disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Digital psychotherapeutics offer promising solutions for anxiety disorders by providing accessible, personalized, and scalable interventions. These platforms often incorporate evidence-based therapeutic techniques, cognitive-behavioural therapy modules, and mindfulness practices to address anxiety symptoms. It's convenient and flexible approach to mental health care fuels the segment demand.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing awareness of mental health issues, rising smartphone penetration, and advancements in technology. The covid-19 pandemic's impact on mental health raised the acceptance of telehealth in the region. China is well-known for its strong technology infrastructure and telemedicine, mobile health applications, & wearable gadgets have seen tremendous improvements in the country. Thereby, robust advancements in telemedicine and digital health technology is likely to continue pushing growth in the region.
North America is projected to have the highest CAGR over the forecast period owing to the favourable reimbursement scenarios. The digital psychotherapeutics industry in the United States is expected to progress as the country's mental health awareness grows. Anxiety, depression, and post-traumatic stress disorder (PTSD) are common mental health illnesses in the United States. North America is a key player in shaping the future of digital psychotherapeutics, fostering innovation and accessibility. The region's well-established healthcare infrastructure, coupled with a growing acceptance of digital interventions, fosters market expansion.
Key players in the market
Some of the key players profiled in the Digital Psychotherapeutics Market include Pear Therapeutics, Akili Interactive, Happify Health, Headspace, Ginger, Lantern, Limbix, Big Health, Mindstrong Health, NeuroFlow, SilverCloud Health, Talkspace, Woebot Health, Kaia Health, Novartis, Spring Health, Koa Health and Meru Health.
In November 2023, Spring Health, the most comprehensive global mental health solution for employers and health plans, announced the launch of a new dedicated teen experience. Spring Health for teens is the latest innovation in the Family Care suite of services, which offers mental health care and support for all ages.
In November 2018, Sandoz, a division of Novartis partnered with Pear Therapeutics and launched reSET - a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA. reSET is a 12-week digital cognitive behavioral therapy program accessed through an app and designed to accompany outpatient care delivered by a physician.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.